Company Update (NASDAQ:REGN): Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol

[PR Newswire] – TARRYTOWN, N.Y. and BRIDGEWATER, N.J., Dec. 15, 2014 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Sanofi US (EURONEXT: SAN and NYSE: SNY ) are collaborating with nationally-recognized … . . . → Read More: Company Update (NASDAQ:REGN): Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol Similar Articles: Market Update (NASDAQ:REGN): EYLEA® (aflibercept) Injection Accepted for Priority Review by FDA for Diabetic Retinopathy in Patients with Diabetic Macular Edema Stock Update: Regeneron Pharmaceuticals Inc (NASDAQ:REGN) – Regeneron cuts top end of eye drug sales forecast Stock Update (NASDAQ:REGN): EYLEA® (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.